Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study-Reference-Cited by-同舟云学术

Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

Published:2020-10-21 Issue:2 Volume:148 Page:396-405
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bonde Jesper¹^ORCID,Floore Arno²,Ejegod Ditte¹,Vink Frederique J.³^ORCID,Hesselink Albertus²,Ven Peter M.⁴,Valenčak Anja Oštrbenk⁵,Pedersen Helle¹,Doorn Saskia²,Quint Wim G.⁶,Petry Karl Ulrich⁷^ORCID,Poljak Mario⁵,Stanczuk Grazyna⁸,Cuschieri Kate⁹^ORCID,Sanjosé Silvia¹⁰,Bleeker Maaike³,Berkhof Johannes⁴,Meijer Chris J. L. M.²³,Heideman Daniëlle A. M.³

Affiliation:

1. Molecular Pathology Laboratory, Department of Pathology Hvidovre Hospital Hvidovre Denmark

2. Self‐screen B.V Amsterdam The Netherlands

3. Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam Amsterdam The Netherlands

4. Department of Epidemiology and Biostatistics Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands

5. Institute of Microbiology and Immunology University of Ljubljana Ljubljana Slovenia

6. DDL Diagnostic Laboratory Rijswijk The Netherlands

7. Department of Gynaecology and Obstetrics Klinikum Wolfsburg Germany

8. Department of Obstetrics and Gynaecology Western Isles Hospital Scotland UK

9. HPV Research Group, Division of Pathology University of Edinburgh Scotland UK

10. Infections and Cancer Laboratory Catalan Institute of Oncology (ICO) Barcelona Spain

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33320

Reference35 articles.

1. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

2. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening

3. Age‐specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting;Leinonen M;J Natl Cancer Inst,2009

4. Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

5. Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study;BMC Medicine;2024-02-05

2. Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women;Vaccines;2023-12-31

3. High-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries;2023-12-12

4. Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands;Diagnostics;2023-12-06

5. HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)—study protocol of a randomised healthcare policy trial;BMC Cancer;2023-11-17